Removal of Aβ Oligomers from the Blood: A Potential Therapeutic System for Alzheimer’s Disease

PURPOSE: Amyloid-β protein (Aβ) is one of the causative proteins of Alzheimer’s disease. We have been developing extracorporeal blood Aβ-removal systems as a method for enhancing Aβ clearance from the brain. We reported previously that medical adsorbents and hemodialyzers removed Aβ monomers from pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Yuta, Sakata, Miwa, Kobayakawa, Moe, Kawachi, Hiroshi, Kawaguchi, Kazunori, Hiki, Yoshiyuki, Kato, Masao, Mori, Mayuko, Hasegawa, Midori, Ohashi, Norimi, Yuzawa, Yukio, Kitaguchi, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064818/
https://www.ncbi.nlm.nih.gov/pubmed/32210564
http://dx.doi.org/10.2147/NDT.S241074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064818/
https://www.ncbi.nlm.nih.gov/pubmed/32210564
http://dx.doi.org/10.2147/NDT.S241074

Ejemplares similares